Medis, the leading commercialization company for the CEE reg

Medis, the leading commercialization company focused on improving access to innovative therapies in the countries of Central and Eastern Europe, has appointed Maja Strnad Cestar as the new CEO, effective August 1, 2023.

Related Keywords

Strnad Cestar , Martina Perhari , Medis Group , World Orphan Drug Alliance , Chief Operating Officer , Chief Business Officer Pharmaceuticals , World Orphan Drug , Eastern Europe , Central And Eastern Europe , Mmedis , Maja Strnad Cestar , Innovative Therapies , Ommercialization ,